Pharma & Biotech

In a decisive move aligning leadership incentives with corporate goals, Ocugen, Inc. has established a substantial performance-based equity award for...

BioNTech has completed its takeover of CureVac, a move that solidifies its commanding position within Germany's mRNA therapeutics landscape. By...

Shares of InnoCan Pharma are staging a technical recovery in early European trading, gaining approximately 6% after a recent sell-off....

Bionxt Solutions has announced significant progress in its proprietary drug delivery technology, securing intellectual property rights for a core patent...

Abbott Laboratories has announced an increase to its shareholder payout while simultaneously revealing mixed institutional trading activity. These developments coincide...

The stock of biotechnology firm Rezolute has collapsed in the wake of a disastrous outcome for its most promising drug...

The competitive landscape for obesity treatments is heating up, fueling speculation about potential industry consolidation. At the center of this...

Shares of biotechnology firm Skye Bioscience are experiencing significant turmoil. The company is now confronting a class action lawsuit filed...

Shares of Gilead Sciences are consolidating near the $120 level following significant clinical and financial developments. The company announced that...

While Clover Health Investments, Corp. (NASDAQ: CLOV) shares continue to face downward pressure, a newly scheduled event has given market...